Other

Royalty Pharma lets Elan takeover bid expire

Royalty Pharma has let its latest takeover bid for Irish drugmaker Elan lapse as it decided against pressing ahead with a court challenge of a requirement that it withdraw the offer.

Health

2008 initiative had minimal impact on pressure ulcer charges

(HealthDay)—The 2008 Hospital-Acquired Conditions Initiative (HACI) payment changes for pressure ulcers have had a minimal effect, according to a study published in the July issue of the Journal of the American Geriatrics ...

Oncology & Cancer

Bundle payment model analysis of emerging breast cancer screening

Bundled payments have been touted as mechanisms to optimize quality and costs. A prior feasibility study evaluating bundled payments for screening mammography episodes predated widespread adoption of digital breast tomosynthesis ...

Diseases, Conditions, Syndromes

Physician payment reform has led to decrease in home-based dialysis

The Medicare program's transition in 2004 to tiered fee-for-service physician reimbursement for dialysis care had the unintended consequence of reducing use of home dialysis, according to a paper co-authored by a nonresident ...

Other

Judge halts Royalty Pharma's bid for Elan stock

Irish drugmaker Elan Corp.'s fight against a takeover bid by Royalty Pharma has spilled into U.S. federal court, where a judge has issued a temporary restraining order preventing Royalty from completing its offer to buy the ...

page 22 from 25